生命科学资讯

FDA chief Makary takes aim at Hims' compounded Wegovy pill plans

Novo's threat to sue Hims over Wegovy pill faces legal hurdle

White House plans to launch TrumpRx Thursday

Veradermics CEO has a great hair day with 122% pop in IPO

#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial

Bristol Myers draws pipeline excitement as several data readouts near

GLP-1s and the Super Bowl

Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex

Telehealth provider Hims goes after Novo's weight loss pill with compounded version

Eikon IPO analysis: Big biotech names, big valuation cut

FTC settles insulin lawsuit with Express Scripts

AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira

Rare pediatric PRV program reauthorized until 2029 via government funding law

GSK’s new CEO eyes more dealmaking, intense pipeline inspection

Veradermics lands $256M IPO for oral Rogaine

Midi Health raises $100M as it plans expansion into urgent care, research

Hims adds Grail's cancer test amid questions about widespread use

Novartis says generics to erode $4B from 2026 sales

Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio

FDA seeks withdrawal of Amgen's Tavneos, company says it won't pull drug